A Current and Future Look at the Market Figures for the Diabetes Drug Industry.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c10773) has announced the addition of Diabetes, Metabolic Syndrome metabolic syndrome n. See syndrome X. Metabolic syndrome A group of risk factors for heart disease, diabetes, and stroke. & Cardiovascular Disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease : Reshaping Tomorrow's Diabetes Market to their offering. The principle objectives of this report are to: --Identify viable technology drivers through a comprehensive look at various platform technologies for diabetes, obesity obesity, condition resulting from excessive storage of fat in the body. Obesity has been defined as a weight more than 20% above what is considered normal according to standard age, height, and weight tables, or by a complex formula known as the body mass index. and metabolic diseases metabolic disease, n a disorder that causes dysfunction of the metabolic action of the body, resulting in loss of control of homeostasis. paraneoplastic syndrome . --Obtain a complete understanding of the chief diabetes, obesity and metabolic diseases tests-predictive, screening, prognostic prog·nos·tic adj. 1. Of, relating to, or useful in prognosis. 2. Of or relating to prediction; predictive. n. 1. A sign or symptom indicating the future course of a disease. 2. , monitoring, pharmacogenomic, and theranostic-from their basic principles to their applications. --Discover feasible market opportunities via an identification of high-growth applications in different therapeutic areas, with a focus on the biggest and expanding markets for diabetes, obesity and metabolic diseases. --Focus on global industry development through an in-depth analysis of the major world markets for molecular diagnostics (1) Software routines that test hardware components (memory, keyboard, disks, etc.). Diagnostics are often stored in ROM chips and activated on startup. (2) Error messages in a programmer's source code that refer to statements or syntax that the compiler or assembler , including forecasts for growth. --Review the blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence testing market including definitions, technology and trends. --Market figures regarding the current value of the diabetes drug market are taken from the most recently available data of the global pharmaceutical industry. Projections and forecasts for the future of the diabetes market ranges from 2004 to 2010. By purchasing this report, you will have: 1. An improved understanding of the current state and future of the diabetes market 2. The latest information on the leading companies engaged in R&D and products in the pipeline 3. The leading perspective of recent drug developments and revelations. 4. Knowledge of the diabetes market as an area of growth, research and investment This report will cover the following categories of diabetes drugs: --Rapid Acting Insulin insulin, hormone secreted by the β cells of the islets of Langerhans, specific groups of cells in the pancreas. Insufficiency of insulin in the body results in diabetes. Insulin was one of the first products to be manufactured using genetic engineering. --Short Activity Insulin --Intermediate Acting Insulin --Long Acting Insulin --Ultra Long Acting Insulin --Insulin Mixtures --Sulfonylureas --Meglitinides --Biguanides --Thiazolidinediones --Alpha-Glucosidase Inhibitors Analysis includes the use of charts and graphs measuring product growth and trends within the marketplace. In addition, a discussion of research into the illness provides the reader with a deeper understanding of the possibilities for future treatment and avenues for possible research and development budgets. Company-specific information, including sales figures sales figures npl → cifras fpl de ventas , drug pipeline status, and research and development trends is provided throughout the report. --Assess the diabetes, obesity and metabolic disease market drivers and bottlenecks, from the perspective of the medical and scientific communities. --Discuss the potential benefits of diabetes, obesity and metabolic disease market for various sectors of the medical and scientific community. --Establish the current total market size and future growth of the diabetes, obesity and metabolic disease market and analyze the current size and growth of therapeutic segments. --Provide current and forecasted market shares by company. --Discuss profit / business opportunities by therapeutic segment. --Provide strategic recommendations for near term business opportunities. --Assess current commercial uses of diabetes, obesity and metabolic disease market. --Assess the blood glucose testing business mode We answer the following questions in this report: --What are the near term business opportunities in the diabetes, obesity and metabolic disease market? --What are the current and forecasted sizes of the diabetes, obesity and metabolic disease market market? --What are the business models currently used by companies in diabetes, obesity and metabolic disease market? --How will drug manufacturers, researchers, physicians, patients and payers influence the diabetes, obesity and metabolic disease market? --What are the drivers and bottlenecks influencing the diabetes, obesity and metabolic disease market? --What are the technologies used in diabetes, obesity and metabolic disease therapies? --Who holds the proprietary rights to diabetes, obesity and metabolic disease market therapeutic technology? --What are current applications of this technology? --What regulatory processes must diabetes, obesity and metabolic disease therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. undergo in the U.S., Japan and Europe? --How will new diabetes, obesity and metabolic disease therapies change treatment and payment paradigms? --How will litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. concerns increase physician use of diabetes, obesity and metabolic disease therapies? --How will diabetes, obesity and metabolic disease therapies reduce adverse drug reactions adverse drug reaction, n a detrimental outcome from a drug. Two types of ADRs exist: Type 1 results from dosage mismatch and Type 2 from rare conditions often as a consequence of a small dose. See also risk or sensitive type. and decrease total patient care cost? --How will diabetes, obesity and metabolic disease therapies reduce health care expenditures? --How will drug development cost and time decrease with diabetes, obesity and metabolic disease therapy use? Topics Covered 1. Overview 2. Introduction 3. Understanding the Metabolic met·a·bol·ic adj. Of, relating to, or resulting from metabolism. Metabolic Refers to the chemical processes of an organ or organism. Conditions Underlying and Associated with Diabetes 4. Current Treatment Paradigms 5. Emerging Oral Anti-diabetes Products 6. Projections for the Anti-diabetes Drug Market 7. Diagnosing Diabetes Using In Vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. Laboratory Tests 8. Insulin Delivery Technologies 9. Market Trends, Challenges and Strategic Options Appendix 1 Appendix 2 INDEX OF FIGURES INDEX OF TABLES Summary This report describes the specific market segment of the pharmaceutical market for diabetes and two of its related diseases, metabolic syndrome and cardiovascular disease. It begins with a textbook textbook Informatics A treatise on a particular subject. See Bible. explanation of the biology underlying diabetes, and then it reviews and evaluates widely accepted pharmaceutical approaches to diabetes that are currently in use. Finally, market forecasts and an analysis of products in the worldwide prescriptions market will help the reader understand the significance of past developments and speculate on future possibilities about the market of diabetes therapies as an area of research and investment. For more information visit http://www.researchandmarkets.com/reports/c10773 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion